A complex deletion/insertion on exon 19 of the EGFR gene predicts response to gefitinib.
Medical Oncology Department, Hospital del Mar, Barcelona, Spain Pathology Department, Hospital del Mar, Barcelona, Spain Radiology Department, Hospital del Mar, Barcelona, Spain.
Ana
A
Luque
Edurne
E
Arriola
Luz
L
Martínez-Avilés
Iván
I
Vollmer
D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics*; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000235:genetics*; D005091:Exons / Q000235:genetics; D005260:Female; D000077156:Gefitinib; D006801:Humans; D054643:INDEL Mutation; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib